{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T20:25:38Z","timestamp":1775766338749,"version":"3.50.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,14]],"date-time":"2020-03-14T00:00:00Z","timestamp":1584144000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,3,14]],"date-time":"2020-03-14T00:00:00Z","timestamp":1584144000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"AIRC","doi-asserted-by":"crossref","award":["21846"],"award-info":[{"award-number":["21846"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Bioinformatics"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The selection and prioritization of drug targets is a central problem in drug discovery. Computational approaches can leverage the growing number of large-scale human genomics and proteomics data to make in-silico target identification, reducing the cost and the time needed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We developed a machine learning approach to score proteins to generate a druggability score of novel targets. In our model we incorporated 70 protein features which included properties derived from the sequence, features characterizing protein functions as well as network properties derived from the protein-protein interaction network. The advantage of this approach is that it is unbiased and even less studied proteins with limited information about their function can score well as most of the features are independent of the accumulated literature. We build models on a training set which consist of targets with approved drugs and a negative set of non-drug targets. The machine learning techniques help to identify the most important combination of features differentiating validated targets from non-targets. We validated our predictions on an independent set of clinical trial drug targets, achieving a high accuracy characterized by an Area Under the Curve (AUC) of 0.89. Our most predictive features included biological function of proteins, network centrality measures, protein essentiality, tissue specificity, localization and solvent accessibility. Our predictions, based on a small set of 102 validated oncology targets, recovered the majority of known drug targets and identifies a novel set of proteins as drug target candidates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We developed a machine learning approach to prioritize proteins according to their similarity to approved drug targets. We have shown that the method proposed is highly predictive on a validation dataset consisting of 277 targets of clinical trial drug confirming that our computational approach is an efficient and cost-effective tool for drug target discovery and prioritization. Our predictions were based on oncology targets and cancer relevant biological functions, resulting in significantly higher scores for targets of oncology clinical trial drugs compared to the scores of targets of trial drugs for other indications. Our approach can be used to make indication specific drug-target prediction by combining generic druggability features with indication specific biological functions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12859-020-3442-9","type":"journal-article","created":{"date-parts":[[2020,3,14]],"date-time":"2020-03-14T06:02:52Z","timestamp":1584165772000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Machine learning prediction of oncology drug targets based on protein and network properties"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2332-314X","authenticated-orcid":false,"given":"Zolt\u00e1n","family":"Dezs\u0151","sequence":"first","affiliation":[]},{"given":"Michele","family":"Ceccarelli","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2020,3,14]]},"reference":[{"key":"3442_CR1","doi-asserted-by":"publisher","first-page":"4610","DOI":"10.1038\/s41467-018-06916-5","volume":"9","author":"JM McFarland","year":"2018","unstructured":"McFarland JM, Ho ZV, Kugener G, Dempster JM, Montgomery PG, Bryan JG, et al. Improved estimation of cancer dependencies from large-scale RNAi screens using model-based normalization and data integration. Nat Commun. 2018;9:4610. https:\/\/doi.org\/10.1038\/s41467-018-06916-5.","journal-title":"Nat Commun."},{"key":"3442_CR2","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/s41586-019-1103-9","volume":"568","author":"FM Behan","year":"2019","unstructured":"Behan FM, Iorio F, Picco G, Gon\u00e7alves E, Beaver CM, Migliardi G, et al. Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens. Nature. 2019;568:511\u20136. https:\/\/doi.org\/10.1038\/s41586-019-1103-9.","journal-title":"Nature."},{"key":"3442_CR3","doi-asserted-by":"publisher","first-page":"923","DOI":"10.3389\/fphar.2018.00923","volume":"9","author":"V Salmaso","year":"2018","unstructured":"Salmaso V, Moro S. Bridging molecular docking to molecular dynamics in exploring ligand-protein recognition process: an overview. Front Pharmacol. 2018;9:923. https:\/\/doi.org\/10.3389\/fphar.2018.00923.","journal-title":"Front Pharmacol."},{"issue":"Database issue","key":"3442_CR4","doi-asserted-by":"publisher","first-page":"D668","DOI":"10.1093\/nar\/gkj067","volume":"34","author":"DS Wishart","year":"2006","unstructured":"Wishart DS, Knox C, Guo AC, Shrivastava S, Hassanali M, Stothard P, et al. DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res. 2006;34(Database issue):D668\u201372. https:\/\/doi.org\/10.1093\/nar\/gkj067.","journal-title":"Nucleic Acids Res."},{"issue":"Database issue","key":"3442_CR5","doi-asserted-by":"publisher","first-page":"D1091","DOI":"10.1093\/nar\/gkt1068","volume":"42","author":"V Law","year":"2014","unstructured":"Law V, Knox C, Djoumbou Y, Jewison T, Guo AC, Liu Y, et al. DrugBank 4.0: shedding new light on drug metabolism. Nucleic Acids Res. 2014;42(Database issue):D1091\u20137. https:\/\/doi.org\/10.1093\/nar\/gkt1068.","journal-title":"Nucleic Acids Res"},{"key":"3442_CR6","doi-asserted-by":"publisher","first-page":"D1121","DOI":"10.1093\/nar\/gkx1076","volume":"46","author":"YH Li","year":"2018","unstructured":"Li YH, Yu CY, Li XX, Zhang P, Tang J, Yang Q, et al. Therapeutic target database update 2018: enriched resource for facilitating bench-to-clinic research of targeted therapeutics. Nucleic Acids Res. 2018;46:D1121\u20137. https:\/\/doi.org\/10.1093\/nar\/gkx1076.","journal-title":"Nucleic Acids Res."},{"key":"3442_CR7","doi-asserted-by":"publisher","first-page":"e1003315","DOI":"10.1371\/journal.pcbi.1003315","volume":"9","author":"K Wang","year":"2013","unstructured":"Wang K, Sun J, Zhou S, Wan C, Qin S, Li C, et al. Prediction of drug-target interactions for drug repositioning only based on genomic expression similarity. PLoS Comput Biol. 2013;9:e1003315. https:\/\/doi.org\/10.1371\/journal.pcbi.1003315.","journal-title":"PLoS Comput Biol."},{"key":"3442_CR8","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1126\/science.1132939","volume":"313","author":"J Lamb","year":"2006","unstructured":"Lamb J, Crawford ED, Peck D, Modell JW, Blat IC, Wrobel MJ, et al. The connectivity map: using gene-expression signatures to connect small molecules, genes, and disease. Science. 2006;313:1929\u201335. https:\/\/doi.org\/10.1126\/science.1132939.","journal-title":"Science."},{"key":"3442_CR9","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/nrc2044","volume":"7","author":"J Lamb","year":"2007","unstructured":"Lamb J. The connectivity map: a new tool for biomedical research. Nat Rev Cancer. 2007;7:54\u201360. https:\/\/doi.org\/10.1038\/nrc2044.","journal-title":"Nat Rev Cancer."},{"key":"3442_CR10","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.tips.2014.07.001","volume":"35","author":"A Ma\u2019ayan","year":"2014","unstructured":"Ma\u2019ayan A, Rouillard AD, Clark NR, Wang Z, Duan Q, Kou Y. Lean big data integration in systems biology and systems pharmacology. Trends Pharmacol Sci. 2014;35:450\u201360. https:\/\/doi.org\/10.1016\/j.tips.2014.07.001.","journal-title":"Trends Pharmacol Sci."},{"key":"3442_CR11","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1089\/cmb.2010.0213","volume":"18","author":"L Perlman","year":"2011","unstructured":"Perlman L, Gottlieb A, Atias N, Ruppin E, Sharan R. Combining drug and gene similarity measures for drug-target elucidation. J Comput Biol. 2011;18:133\u201345. https:\/\/doi.org\/10.1089\/cmb.2010.0213.","journal-title":"J Comput Biol."},{"key":"3442_CR12","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1109\/TCBB.2014.2325031","volume":"11","author":"S Fakhraei","year":"2014","unstructured":"Fakhraei S, Huang B, Raschid L, Getoor L. Network-based drug-target interaction prediction with probabilistic soft logic. IEEE\/ACM Trans Comput Biol Bioinform. 2014;11:775\u201387. https:\/\/doi.org\/10.1109\/TCBB.2014.2325031.","journal-title":"IEEE\/ACM Trans Comput Biol Bioinform."},{"key":"3442_CR13","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.chembiol.2016.07.023","volume":"23","author":"KM Gayvert","year":"2016","unstructured":"Gayvert KM, Madhukar NS, Elemento O. A data-driven approach to predicting successes and failures of clinical trials. Cell Chem Biol. 2016;23:1294\u2013301. https:\/\/doi.org\/10.1016\/j.chembiol.2016.07.023.","journal-title":"Cell Chem Biol."},{"key":"3442_CR14","doi-asserted-by":"publisher","first-page":"e0117955","DOI":"10.1371\/journal.pone.0117955","volume":"10","author":"SC Bull","year":"2015","unstructured":"Bull SC, Doig AJ. Properties of protein drug target classes. PLoS ONE. 2015;10:e0117955. https:\/\/doi.org\/10.1371\/journal.pone.0117955.","journal-title":"PLoS ONE."},{"key":"3442_CR15","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1093\/bioinformatics\/btp002","volume":"25","author":"TM Bakheet","year":"2009","unstructured":"Bakheet TM, Doig AJ. Properties and identification of human protein drug targets. Bioinformatics. 2009;25:451\u20137. https:\/\/doi.org\/10.1093\/bioinformatics\/btp002.","journal-title":"Bioinformatics."},{"issue":"Suppl 7","key":"3442_CR16","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1186\/s12859-017-1639-3","volume":"18","author":"B Kim","year":"2017","unstructured":"Kim B, Jo J, Han J, Park C, Lee H. In silico re-identification of properties of drug target proteins. BMC Bioinformatics. 2017;18(Suppl 7):248. https:\/\/doi.org\/10.1186\/s12859-017-1639-3.","journal-title":"BMC Bioinformatics"},{"key":"3442_CR17","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/1471-2105-11-228","volume":"11","author":"L Cerulo","year":"2010","unstructured":"Cerulo L, Elkan C, Ceccarelli M. Learning gene regulatory networks from only positive and unlabeled data. BMC Bioinformatics. 2010;11:228. https:\/\/doi.org\/10.1186\/1471-2105-11-228.","journal-title":"BMC Bioinformatics."},{"key":"3442_CR18","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1145\/1401890.1401920","volume-title":"Proceeding of the 14th ACM SIGKDD international conference on Knowledge discovery and data mining - KDD 08","author":"C Elkan","year":"2008","unstructured":"Elkan C, Noto K. Learning classifiers from only positive and unlabeled data. In: Proceeding of the 14th ACM SIGKDD international conference on Knowledge discovery and data mining - KDD 08. New York: ACM Press; 2008. p. 213. https:\/\/doi.org\/10.1145\/1401890.1401920."},{"key":"3442_CR19","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.aca.2015.02.032","volume":"871","author":"Z-C Li","year":"2015","unstructured":"Li Z-C, Zhong W-Q, Liu Z-Q, Huang M-H, Xie Y, Dai Z, et al. Large-scale identification of potential drug targets based on the topological features of human protein-protein interaction network. Anal Chim Acta. 2015;871:18\u201327. https:\/\/doi.org\/10.1016\/j.aca.2015.02.032.","journal-title":"Anal Chim Acta."},{"key":"3442_CR20","doi-asserted-by":"publisher","first-page":"17417","DOI":"10.1038\/srep17417","volume":"5","author":"Z Isik","year":"2015","unstructured":"Isik Z, Baldow C, Cannistraci CV, Schroeder M. Drug target prioritization by perturbed gene expression and network information. Sci Rep. 2015;5:17417. https:\/\/doi.org\/10.1038\/srep17417.","journal-title":"Sci Rep."},{"key":"3442_CR21","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1080\/00498250600861660","volume":"36","author":"S Ekins","year":"2006","unstructured":"Ekins S, Bugrim A, Brovold L, Kirillov E, Nikolsky Y, Rakhmatulin E, et al. Algorithms for network analysis in systems-ADME\/Tox using the MetaCore and MetaDrug platforms. Xenobiotica. 2006;36:877\u2013901. https:\/\/doi.org\/10.1080\/00498250600861660.","journal-title":"Xenobiotica."},{"issue":"Suppl","key":"3442_CR22","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1093\/nar\/19.suppl.2247","volume":"19","author":"A Bairoch","year":"1991","unstructured":"Bairoch A, Boeckmann B. The SWISS-PROT protein sequence data bank. Nucleic Acids Res. 1991;19(Suppl):2247\u20139. https:\/\/doi.org\/10.1093\/nar\/19.suppl.2247.","journal-title":"Nucleic Acids Res."},{"key":"3442_CR23","doi-asserted-by":"publisher","first-page":"e1003484","DOI":"10.1371\/journal.pgen.1003484","volume":"9","author":"B Georgi","year":"2013","unstructured":"Georgi B, Voight BF, Bu\u0107an M. From mouse to human: evolutionary genomics analysis of human orthologs of essential genes. PLoS Genet. 2013;9:e1003484. https:\/\/doi.org\/10.1371\/journal.pgen.1003484.","journal-title":"PLoS Genet."},{"key":"3442_CR24","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2019","unstructured":"Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47:D607\u201313. https:\/\/doi.org\/10.1093\/nar\/gky1131.","journal-title":"Nucleic Acids Res."},{"key":"3442_CR25","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1038\/nbt1338","volume":"25","author":"MA Yildirim","year":"2007","unstructured":"Yildirim MA, Goh K-I, Cusick ME, Barab\u00e1si A-L, Vidal M. Drug-target network. Nat Biotechnol. 2007;25:1119\u201326. https:\/\/doi.org\/10.1038\/nbt1338.","journal-title":"Nat Biotechnol."},{"key":"3442_CR26","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/1741-7007-6-49","volume":"6","author":"Z Dezso","year":"2008","unstructured":"Dezso Z, Nikolsky Y, Sviridov E, Shi W, Serebriyskaya T, Dosymbekov D, et al. A comprehensive functional analysis of tissue specificity of human gene expression. BMC Biol. 2008;6:49. https:\/\/doi.org\/10.1186\/1741-7007-6-49.","journal-title":"BMC Biol."},{"key":"3442_CR27","doi-asserted-by":"publisher","DOI":"10.1145\/1401890.1401920","volume-title":"Learning classifiers from only positive and unlabeled data","author":"C Elkan","year":"2008","unstructured":"Elkan C, Noto K. Learning classifiers from only positive and unlabeled data. portal.acm.org. 2008."},{"key":"3442_CR28","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1109\/TKDE.2008.239","volume":"21","author":"H He","year":"2009","unstructured":"He H, Garcia EA. Learning from imbalanced data. IEEE Trans Knowl Data Eng. 2009;21:1263\u201384. https:\/\/doi.org\/10.1109\/TKDE.2008.239.","journal-title":"IEEE Trans Knowl Data Eng."},{"key":"3442_CR29","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/BF00058655","volume":"24","author":"L Breiman","year":"1996","unstructured":"Breiman L. Bagging predictors. Mach Learn. 1996;24:123\u201340. https:\/\/doi.org\/10.1007\/BF00058655.","journal-title":"Mach Learn."},{"key":"3442_CR30","doi-asserted-by":"publisher","DOI":"10.1201\/9781315139470","volume-title":"Classification and regression trees","author":"L Breiman","year":"1984","unstructured":"Breiman L, Friedman JH, Olshen RA, Stone CJ. Classification and regression trees. Monterey: Wadsworth & Brooks\/Cole Advanced Books & Software; 1984. https:\/\/doi.org\/10.1201\/9781315139470."},{"key":"3442_CR31","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/35075138","volume":"411","author":"H Jeong","year":"2001","unstructured":"Jeong H, Mason SP, Barab\u00e1si AL, Oltvai ZN. Lethality and centrality in protein networks. Nature. 2001;411:41\u20132. https:\/\/doi.org\/10.1038\/35075138.","journal-title":"Nature."},{"key":"3442_CR32","doi-asserted-by":"publisher","first-page":"7233","DOI":"10.1038\/s41598-019-43829-9","volume":"9","author":"M Ryaboshapkina","year":"2019","unstructured":"Ryaboshapkina M, Hammar M. Tissue-specific genes as an underutilized resource in drug discovery. Sci Rep. 2019;9:7233. https:\/\/doi.org\/10.1038\/s41598-019-43829-9.","journal-title":"Sci Rep."},{"key":"3442_CR33","doi-asserted-by":"publisher","first-page":"A68","DOI":"10.5114\/wo.2014.47136","volume":"19","author":"K Tomczak","year":"2015","unstructured":"Tomczak K, Czerwi\u0144ska P, Wiznerowicz M. The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge. Contemp Oncol (Pozn). 2015;19:A68\u201377. https:\/\/doi.org\/10.5114\/wo.2014.47136.","journal-title":"Contemp Oncol (Pozn)."},{"key":"3442_CR34","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1016\/j.cell.2018.10.022","volume":"175","author":"BJ Schmiedel","year":"2018","unstructured":"Schmiedel BJ, Singh D, Madrigal A, Valdovino-Gonzalez AG, White BM, Zapardiel-Gonzalo J, et al. Impact of genetic polymorphisms on human immune cell gene expression. Cell. 2018;175:1701\u20131715.e16. https:\/\/doi.org\/10.1016\/j.cell.2018.10.022.","journal-title":"Cell"},{"key":"3442_CR35","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1038\/nrd2961","volume":"8","author":"B Munos","year":"2009","unstructured":"Munos B. Lessons from 60 years of pharmaceutical innovation. Nat Rev Drug Discov. 2009;8:959\u201368. https:\/\/doi.org\/10.1038\/nrd2961.","journal-title":"Nat Rev Drug Discov."},{"key":"3442_CR36","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.pharmthera.2013.01.016","volume":"138","author":"P Csermely","year":"2013","unstructured":"Csermely P, Korcsm\u00e1ros T, Kiss HJM, London G, Nussinov R. Structure and dynamics of molecular networks: a novel paradigm of drug discovery: a comprehensive review. Pharmacol Ther. 2013;138:333\u2013408. https:\/\/doi.org\/10.1016\/j.pharmthera.2013.01.016.","journal-title":"Pharmacol Ther."},{"key":"3442_CR37","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1752-0509-6-15","volume":"6","author":"M Li","year":"2012","unstructured":"Li M, Zhang H, Wang J, Pan Y. A new essential protein discovery method based on the integration of protein-protein interaction and gene expression data. BMC Syst Biol. 2012;6:15. https:\/\/doi.org\/10.1186\/1752-0509-6-15.","journal-title":"BMC Syst Biol."},{"key":"3442_CR38","doi-asserted-by":"publisher","first-page":"eaag1166","DOI":"10.1126\/scitranslmed.aag1166","volume":"9","author":"C Finan","year":"2017","unstructured":"Finan C, Gaulton A, Kruger FA, Lumbers RT, Shah T, Engmann J, et al. The druggable genome and support for target identification and validation in drug development. Sci Transl Med. 2017;9:eaag1166. https:\/\/doi.org\/10.1126\/scitranslmed.aag1166.","journal-title":"Sci Transl Med."},{"key":"3442_CR39","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.tig.2018.04.004","volume":"34","author":"M Floris","year":"2018","unstructured":"Floris M, Olla S, Schlessinger D, Cucca F. Genetic-driven druggable target identification and validation. Trends Genet. 2018;34:558\u201370. https:\/\/doi.org\/10.1016\/j.tig.2018.04.004.","journal-title":"Trends Genet."},{"key":"3442_CR40","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1038\/nrd1549","volume":"3","author":"DB Kitchen","year":"2004","unstructured":"Kitchen DB, Decornez H, Furr JR, Bajorath J. Docking and scoring in virtual screening for drug discovery: methods and applications. Nat Rev Drug Discov. 2004;3:935\u201349. https:\/\/doi.org\/10.1038\/nrd1549.","journal-title":"Nat Rev Drug Discov."},{"key":"3442_CR41","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/s0168-9525(00)02024-2","volume":"16","author":"P Rice","year":"2000","unstructured":"Rice P, Longden I, Bleasby A. EMBOSS: the european molecular biology open software suite. Trends Genet. 2000;16:276\u20137. https:\/\/doi.org\/10.1016\/s0168-9525(00)02024-2.","journal-title":"Trends Genet."},{"key":"3442_CR42","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/nature24277","volume":"550","author":"GTEx Consortium","year":"2017","unstructured":"GTEx Consortium, Laboratory, Data Analysis &Coordinating Center (LDACC)\u2014Analysis Working Group, Statistical Methods groups\u2014Analysis Working Group, Enhancing GTEx (eGTEx) groups, NIH Common Fund, NIH\/NCI, et al. Genetic effects on gene expression across human tissues. Nature. 2017;550:204\u201313. https:\/\/doi.org\/10.1038\/nature24277.","journal-title":"Nature."},{"key":"3442_CR43","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","volume":"347","author":"M Uhl\u00e9n","year":"2015","unstructured":"Uhl\u00e9n M, Fagerberg L, Hallstr\u00f6m BM, Lindskog C, Oksvold P, Mardinoglu A, et al. Proteomics. Tissue-based map of the human proteome. Science. 2015;347:1260419. https:\/\/doi.org\/10.1126\/science.1260419.","journal-title":"Science"},{"key":"3442_CR44","doi-asserted-by":"publisher","first-page":"R33","DOI":"10.1186\/gb-2005-6-4-r33","volume":"6","author":"J Schug","year":"2005","unstructured":"Schug J, Schuller W-P, Kappen C, Salbaum JM, Bucan M, Stoeckert CJ. Promoter features related to tissue specificity as measured by Shannon entropy. Genome Biol. 2005;6:R33. https:\/\/doi.org\/10.1186\/gb-2005-6-4-r33.","journal-title":"Genome Biol."},{"key":"3442_CR45","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1006\/jmbi.1999.3310","volume":"294","author":"N Blom","year":"1999","unstructured":"Blom N, Gammeltoft S, Brunak S. Sequence and structure-based prediction of eukaryotic protein phosphorylation sites. J Mol Biol. 1999;294:1351\u201362. https:\/\/doi.org\/10.1006\/jmbi.1999.3310.","journal-title":"J Mol Biol."},{"key":"3442_CR46","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1093\/bioinformatics\/btu852","volume":"31","author":"F Li","year":"2015","unstructured":"Li F, Li C, Wang M, Webb GI, Zhang Y, Whisstock JC, et al. GlycoMine: a machine learning-based approach for predicting N-, C- and O-linked glycosylation in the human proteome. Bioinformatics. 2015;31:1411\u20139. https:\/\/doi.org\/10.1093\/bioinformatics\/btu852.","journal-title":"Bioinformatics."},{"key":"3442_CR47","doi-asserted-by":"publisher","first-page":"3193","DOI":"10.1093\/nar\/gki633","volume":"33","author":"H Chen","year":"2005","unstructured":"Chen H, Zhou H-X. Prediction of solvent accessibility and sites of deleterious mutations from protein sequence. Nucleic Acids Res. 2005;33:3193\u20139. https:\/\/doi.org\/10.1093\/nar\/gki633.","journal-title":"Nucleic Acids Res."},{"key":"3442_CR48","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/0022-2836(78)90297-8","volume":"120","author":"J Garnier","year":"1978","unstructured":"Garnier J, Osguthorpe DJ, Robson B. Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular proteins. J Mol Biol. 1978;120:97\u2013120. https:\/\/doi.org\/10.1016\/0022-2836(78)90297-8.","journal-title":"J Mol Biol."},{"key":"3442_CR49","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/s41587-019-0036-z","volume":"37","author":"JJA Armenteros","year":"2019","unstructured":"Armenteros JJA, Tsirigos KD, S\u00f8nderby CK, Petersen TN, Winther O, Brunak S, et al. SignalP 5.0 improves signal peptide predictions using deep neural networks. Nat Biotechnol. 2019;37:420\u20133. https:\/\/doi.org\/10.1038\/s41587-019-0036-z.","journal-title":"Nat Biotechnol."},{"key":"3442_CR50","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1002\/prot.21018","volume":"64","author":"C-S Yu","year":"2006","unstructured":"Yu C-S, Chen Y-C, Lu C-H, Hwang J-K. Prediction of protein subcellular localization. Proteins. 2006;64:643\u201351. https:\/\/doi.org\/10.1002\/prot.21018.","journal-title":"Proteins."},{"key":"3442_CR51","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1006\/jmbi.2000.4315","volume":"305","author":"A Krogh","year":"2001","unstructured":"Krogh A, Larsson B, von Heijne G, Sonnhammer ELL. Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J Mol Biol. 2001;305:567\u201380. https:\/\/doi.org\/10.1006\/jmbi.2000.4315.","journal-title":"J Mol Biol"}],"container-title":["BMC Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-020-3442-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12859-020-3442-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-020-3442-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,13]],"date-time":"2021-03-13T19:04:56Z","timestamp":1615662296000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbioinformatics.biomedcentral.com\/articles\/10.1186\/s12859-020-3442-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,14]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["3442"],"URL":"https:\/\/doi.org\/10.1186\/s12859-020-3442-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.15798\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.15798\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.15798\/v3","asserted-by":"object"}]},"ISSN":["1471-2105"],"issn-type":[{"value":"1471-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,14]]},"assertion":[{"value":"24 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"ZD is an employee of ABBVIE Biotherapeutics, Redwood City, CA. MC has been employee of ABBVIE.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"104"}}